244 related articles for article (PubMed ID: 19071177)
41. Do apoptotic Plasmodium-infected hepatocytes initiate protective immune responses?
Renia L; Maranon C; Hosmalin A; Gruner AC; Silvie O; Snounou G
J Infect Dis; 2006 Jan; 193(1):163-4; author reply 164-5. PubMed ID: 16323145
[No Abstract] [Full Text] [Related]
42. Mosquito bite immunization with radiation-attenuated Plasmodium falciparum sporozoites: safety, tolerability, protective efficacy and humoral immunogenicity.
Hickey BW; Lumsden JM; Reyes S; Sedegah M; Hollingdale MR; Freilich DA; Luke TC; Charoenvit Y; Goh LM; Berzins MP; Bebris L; Sacci JB; De La Vega P; Wang R; Ganeshan H; Abot EN; Carucci DJ; Doolan DL; Brice GT; Kumar A; Aguiar J; Nutman TB; Leitman SF; Hoffman SL; Epstein JE; Richie TL
Malar J; 2016 Jul; 15(1):377. PubMed ID: 27448805
[TBL] [Abstract][Full Text] [Related]
43. Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccine.
Senkpeil L; Bhardwaj J; Little MR; Holla P; Upadhye A; Fusco EM; Swanson PA; Wiegand RE; Macklin MD; Bi K; Flynn BJ; Yamamoto A; Gaskin EL; Sather DN; Oblak AL; Simpson E; Gao H; Haining WN; Yates KB; Liu X; Murshedkar T; Richie TL; Sim BKL; Otieno K; Kariuki S; Xuei X; Liu Y; Polidoro RB; Hoffman SL; Oneko M; Steinhardt LC; Schmidt NW; Seder RA; Tran TM
JCI Insight; 2024 Apr; 9(11):. PubMed ID: 38687615
[TBL] [Abstract][Full Text] [Related]
44. Novel approaches to whole sporozoite vaccination against malaria.
Bijker EM; Borrmann S; Kappe SH; Mordmüller B; Sack BK; Khan SM
Vaccine; 2015 Dec; 33(52):7462-8. PubMed ID: 26469716
[TBL] [Abstract][Full Text] [Related]
45. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites.
Kumar KA; Sano G; Boscardin S; Nussenzweig RS; Nussenzweig MC; Zavala F; Nussenzweig V
Nature; 2006 Dec; 444(7121):937-40. PubMed ID: 17151604
[TBL] [Abstract][Full Text] [Related]
46. Protective efficacy and safety of radiation-attenuated and chemo-attenuated Plasmodium Falciparum sporozoite vaccines against controlled and natural malaria infection: a systematic review and meta-analysis of randomized controlled trials.
Abuelazm MT; Elzeftawy MA; Kamal MA; Badr H; Gamal M; Aboulgheit M; Abdelazeem B; Abd-Elsalam S; Abouzid M
Infection; 2024 Jun; 52(3):707-722. PubMed ID: 38319556
[TBL] [Abstract][Full Text] [Related]
47. In vitro survival and retention of infectivity of Plasmodium yoelii sporozoites over extended periods of time.
Siu NF; Sedegah M; Hoffman SL
J Parasitol; 1994 Oct; 80(5):826-9. PubMed ID: 7931920
[TBL] [Abstract][Full Text] [Related]
48. Protective immunity induced by daily bites from irradiated mosquitoes infected with Plasmodium yoelii.
Wong KA; Zhou A; Rodriguez A
Parasite Immunol; 2008 Sep; 30(9):482-6. PubMed ID: 18761489
[TBL] [Abstract][Full Text] [Related]
49. First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers.
Spring M; Murphy J; Nielsen R; Dowler M; Bennett JW; Zarling S; Williams J; de la Vega P; Ware L; Komisar J; Polhemus M; Richie TL; Epstein J; Tamminga C; Chuang I; Richie N; O'Neil M; Heppner DG; Healer J; O'Neill M; Smithers H; Finney OC; Mikolajczak SA; Wang R; Cowman A; Ockenhouse C; Krzych U; Kappe SH
Vaccine; 2013 Oct; 31(43):4975-83. PubMed ID: 24029408
[TBL] [Abstract][Full Text] [Related]
50. Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines.
Richie TL; Billingsley PF; Sim BK; James ER; Chakravarty S; Epstein JE; Lyke KE; Mordmüller B; Alonso P; Duffy PE; Doumbo OK; Sauerwein RW; Tanner M; Abdulla S; Kremsner PG; Seder RA; Hoffman SL
Vaccine; 2015 Dec; 33(52):7452-61. PubMed ID: 26469720
[TBL] [Abstract][Full Text] [Related]
51. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine.
Seder RA; Chang LJ; Enama ME; Zephir KL; Sarwar UN; Gordon IJ; Holman LA; James ER; Billingsley PF; Gunasekera A; Richman A; Chakravarty S; Manoj A; Velmurugan S; Li M; Ruben AJ; Li T; Eappen AG; Stafford RE; Plummer SH; Hendel CS; Novik L; Costner PJ; Mendoza FH; Saunders JG; Nason MC; Richardson JH; Murphy J; Davidson SA; Richie TL; Sedegah M; Sutamihardja A; Fahle GA; Lyke KE; Laurens MB; Roederer M; Tewari K; Epstein JE; Sim BK; Ledgerwood JE; Graham BS; Hoffman SL;
Science; 2013 Sep; 341(6152):1359-65. PubMed ID: 23929949
[TBL] [Abstract][Full Text] [Related]
52. Exploring immunological mechanisms of the whole sporozoite vaccination against P. falciparum malaria.
Mo AX; Pesce J; Hall BF
Vaccine; 2015 Jun; 33(25):2851-7. PubMed ID: 25917675
[TBL] [Abstract][Full Text] [Related]
53. Colocalization of a CD1d-Binding Glycolipid with a Radiation-Attenuated Sporozoite Vaccine in Lymph Node-Resident Dendritic Cells for a Robust Adjuvant Effect.
Li X; Kawamura A; Andrews CD; Miller JL; Wu D; Tsao T; Zhang M; Oren D; Padte NN; Porcelli SA; Wong CH; Kappe SH; Ho DD; Tsuji M
J Immunol; 2015 Sep; 195(6):2710-21. PubMed ID: 26254338
[TBL] [Abstract][Full Text] [Related]
54. Quantification of Plasmodium knowlesi versus Plasmodium falciparum in the rhesus liver: implications for malaria vaccine studies in rhesus models.
Shears MJ; Seilie AM; Kim Lee Sim B; Hoffman SL; Murphy SC
Malar J; 2020 Aug; 19(1):313. PubMed ID: 32867784
[TBL] [Abstract][Full Text] [Related]
55. Development of whole sporozoite malaria vaccines.
Hollingdale MR; Sedegah M
Expert Rev Vaccines; 2017 Jan; 16(1):45-54. PubMed ID: 27327875
[TBL] [Abstract][Full Text] [Related]
56. Structure-activity-based design of a synthetic malaria peptide eliciting sporozoite inhibitory antibodies in a virosomal formulation.
Okitsu SL; Kienzl U; Moehle K; Silvie O; Peduzzi E; Mueller MS; Sauerwein RW; Matile H; Zurbriggen R; Mazier D; Robinson JA; Pluschke G
Chem Biol; 2007 May; 14(5):577-87. PubMed ID: 17524988
[TBL] [Abstract][Full Text] [Related]
57. Plasmodium falciparum: effect of radiation on levels of gene transcripts in sporozoites.
Hoffman BU; Chattopadhyay R
Exp Parasitol; 2008 Feb; 118(2):247-52. PubMed ID: 17935717
[TBL] [Abstract][Full Text] [Related]
58. Expression of human CD81 differently affects host cell susceptibility to malaria sporozoites depending on the Plasmodium species.
Silvie O; Greco C; Franetich JF; Dubart-Kupperschmitt A; Hannoun L; van Gemert GJ; Sauerwein RW; Levy S; Boucheix C; Rubinstein E; Mazier D
Cell Microbiol; 2006 Jul; 8(7):1134-46. PubMed ID: 16819966
[TBL] [Abstract][Full Text] [Related]
59. Pre-erythrocytic stage malaria vaccines: time for a change in path.
Druilhe P; Barnwell JW
Curr Opin Microbiol; 2007 Aug; 10(4):371-8. PubMed ID: 17709281
[TBL] [Abstract][Full Text] [Related]
60. Genetically modified Plasmodium highlights the potential of whole parasite vaccine strategies.
Good MF
Trends Immunol; 2005 Jun; 26(6):295-7. PubMed ID: 15922944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
